While the world has largely moved past the acute phase of the COVID-19 pandemic, the infectious disease landscape in May 2026 is far from quiet. From the emergence of the 'Cicada' variant and a ...

The World Health Assembly, the main decision making body of the World Health Organization, is meeting this year in Geneva ...

AI is transforming global health and infectious disease science, bringing new opportunities but could also exacerbate existing disparities, according to Matt Ferrari, professor of biology. In this Q&A ...

Spencer is a public-health professor and emergency-medicine physician at Brown University. Bhadelia is an associate professor of infectious diseases and the founding director of Boston University’s ...

We can no longer qualify certain threats as problems “over there.” Local phenomena can create consequences that involve the entire world. Nowhere is this better illustrated than in the control of ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

SYDNEY--(BUSINESS WIRE)--Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies ...

Despite overall declines in premature non-communicable disease deaths, the study reveals faltering progress driven by uneven regional trends and emerging health threats. Probability of dying from an ...